logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Cost-effectiveness of breast cancer screening in Spain.

    Article - En anglais

    In the last several years, the development of an effective breast cancer screening procedure has increased the possibility of the early detection of this cancer.

    We investigated the cost-effectiveness of a breast cancer screening program to screen 100,000 women 50-64 years of age in Catalonia (Spain).

    The cost-effectiveness ratio was measured in terms of the cost per cancer detected comparing program costs to the estimated number of cancers detected.

    We assumed a participation rate, sensitivity, and specificity of 70%, 92%, and 94%, respectively, and that 0.36 breast cancers could be detected per 100 women screened.

    We estimated a total cost of $2.1 million with $1.4 million for the mammographic stage and $0.7 million for the detection of the true positive mammographic results.

    The cost per woman screened was $30.

    We estimated that 252 cases of breast cancer could be detected with the program.

    The cost-effectiveness ratio obtained in this study was $8,424 per cancer detected.

    Sensitivity analysis has shown that cost-effectiveness results are sensitive to the variations in the following variables : specificity, cancer detection rate, and screening costs.

    In planning preventive programs, breast cancer screening should be considered one of the priorities.

    Mots-clés Pascal : Tumeur maligne, Glande mammaire, Dépistage, Analyse coût efficacité, Economie santé, Programme sanitaire, Evaluation, Femme, Homme, Espagne, Europe, Prévention, Mammographie, Radiodiagnostic, Glande mammaire pathologie

    Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Medical screening, Cost efficiency analysis, Health economy, Sanitary program, Evaluation, Woman, Human, Spain, Europe, Prevention, Mammography, Radiodiagnosis, Mammary gland diseases

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0240095

    Code Inist : 002B20E01. Création : 199608.